Carregant...
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis
BACKGROUND: Patient‐reported outcome (PRO) measures historically used in inflammatory bowel disease have been considered inadequate to support future drug labelling claims by regulatory agencies. AIMS: To develop PRO tools for use in Crohn's disease (CD) and ulcerative colitis (UC) following gu...
Guardat en:
| Publicat a: | Aliment Pharmacol Ther |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317756/ https://ncbi.nlm.nih.gov/pubmed/32319120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15726 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|